24/7 Helpline: +1 626 539 9760
  • Home/
  • Press Releases/
  • Micro Tech Dominates Global Interventional Pulmonology Device Market with More than 40% Share

Interventional pulmonology uses non-surgical, minimally invasive procedures for the diagnosis and treatment of lung cancer, thoracic cancer, tracheal cancer, and other diseases related to the respiratory system. It relies on endoscopic techniques, which involve inserting an instrument into the human body to view internal organs and tissues and to conduct additional procedures. Interventional pulmonary medicine is also used to treat related symptoms that may cause discomfort, such as shortness of breath, coughing, and chest pain.


Interventional pulmonology has revolutionized the field of pulmonary (related to the lungs and breathing) medicine by providing the most advanced minimally invasive procedures to diagnose and treat both malignant and non-malignant disorders of the lungs and airways. Procedures for interventional pulmonology include: Bronchoscopes, Pleuroscopes, Respiratory Endotherapy Devices (Aspiration Needles, Biopsy Forceps, Biopsy brush, Biopsy Needles, pulmonary catheter, balloon dilatation catheter), Airway Stents, Pleural Catheters, Endobronchial Valves, Bronchial Thermoplasty Systems, Tracheotomy Tube, etc.


Micro Tech is the largest player in global interventional pulmonology device market. In 2021, the China-based company owns more than 40% sales share globally. However, compared with the international players, the price of the company’s  interventional pulmonology device is much lower, which leads to low revenue share. Companies like Boston Scientific, Olympus, Medtronic, owning advanced technology, provide middle and high end products to the market and hold largest share in terms of revenue.


The market driver of global interventional pulmonology device is mainly growing incidence of lung cancer, rising CO2 emission, expansion of medical device industry, surging COPD mortality rate, increasing elderly population and increasing public awareness. Global Interventional Pulmonology Device market size is USD 1744 million in 2022 from USD 1549 million in 2021, with a change of 12.55% between 2021 and 2022. The global Interventional Pulmonology Device market size will reach USD 2699 million in 2028, growing at a CAGR of 7.56% over the analysis period.


Read More Information:


About Us:

QYResearch provides Market Research Reports for clients all over the world. As of now, QYResearch data as following:

62000 + Clients(cover 100% the world strong 500 companies and most industries’ leading players such as TOP5 players)

7800 + Experts(most of them with more than 15 years’ experience in their industry and professional knowledge both in market and technology)

300 + Data Base(40% government related data base, 30% third part data base, 10% international agencies data base, 30% technology and market data base)

2 Million + Reports(cover almost all industries and most detailed products such as product model level research reports, where you can find all what you need in one shop)

1000 + Custom Research Projects(most clients need custom research service and QYResearch keeps offering good and depth service for them)

30 + Roles Data Interview Checking System(only QYResearch uses such interview system with more than 30 roles in order to confirm the data reliability)

13 + Years focus market research and continues to support the client success.


Media Contact:

Rahul Singh - Digital Marketing Director

Contact: +91 7028 920 828



Sales Contact US:

USA Registered Office: QY Research, INC. 

17890 Castleton, Suite 369,

City of industry, CA - 91748

Emails –

Web –

©2007-2026 QY Research All Rights Reserved.